Here's Why Dicerna Pharmaceuticals Is Falling Today
Shares of Dicerna Pharmaceuticals (NASDAQ: DRNA) fell more than 11% today for no apparent reason. However, individual investors who have been following the biopharma know that the stock has erupted higher in the second half of 2019. Shares have gained 63% in the last three months -- and that includes the tumble today.
Today's drop appears to be a simple correction. Investors with a long-term mindset should find no cause for concern, especially given multiple positive announcements in recent months with Roche, Novo Nordisk, and Alexion Pharmaceuticals. As of 2:20 p.m. EST, the pharma stock had settled to a 10% loss.
Image source: Getty Images.
Source Fool.com
